These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29701928)

  • 1. Prevention of Dopamine Dysregulation Syndrome in Parkinson's Disease: A Case Report.
    Luchsinger WT; Gambhir N; DeMoss D
    Prim Care Companion CNS Disord; 2018 Apr; 20(2):. PubMed ID: 29701928
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex, drugs and Parkinson's disease.
    Ushe M; Perlmutter JS
    Brain; 2013 Feb; 136(Pt 2):371-3. PubMed ID: 23413258
    [No Abstract]   [Full Text] [Related]  

  • 3. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
    Bienfait KL; Menza M; Mark MH; Dobkin RD
    J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impulse control disorders associated with dopaminergic agonists in Parkinson's disease. Case report].
    Gamboa Arango A; Bernal Bernal MT; Duaso Magaña E
    Rev Esp Geriatr Gerontol; 2016; 51(5):304-5. PubMed ID: 27016028
    [No Abstract]   [Full Text] [Related]  

  • 5. Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease.
    Politis M; Loane C; Wu K; O'Sullivan SS; Woodhead Z; Kiferle L; Lawrence AD; Lees AJ; Piccini P
    Brain; 2013 Feb; 136(Pt 2):400-11. PubMed ID: 23378222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence and clinical characteristics of hypersexuality in patients with Parkinson's disease following dopaminergic therapy: A systematic literature review.
    Nakum S; Cavanna AE
    Parkinsonism Relat Disord; 2016 Apr; 25():10-6. PubMed ID: 26923525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulse control symptoms in patients with Parkinson's disease: The influence of dopaminergic agonist.
    Vargas AP; Vaz LS; Reuter A; Couto CM; Costa Cardoso FE
    Parkinsonism Relat Disord; 2019 Nov; 68():17-21. PubMed ID: 31621612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulse control disorders in Parkinson's disease.
    Weintraub D; Potenza MN
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
    Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulse control disorder-linked hypersexuality complicated by disseminated gonococcal infection in a patient with Parkinson's disease.
    Moegle C; Grillon A; Anheim M; Lipsker D; Velter C
    Rev Neurol (Paris); 2020 May; 176(4):292-293. PubMed ID: 32139181
    [No Abstract]   [Full Text] [Related]  

  • 11. Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list.
    Fusaroli M; Raschi E; Contin M; Sambati L; Menchetti M; Fioritti A; Poluzzi E
    Parkinsonism Relat Disord; 2021 Sep; 90():79-83. PubMed ID: 34399162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.
    Girard R; Obeso I; Thobois S; Park SA; Vidal T; Favre E; Ulla M; Broussolle E; Krack P; Durif F; Dreher JC
    Brain; 2019 Jan; 142(1):146-162. PubMed ID: 30590514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson's Disease.
    Redenšek S; Jenko Bizjan B; Trošt M; Dolžan V
    Int J Neuropsychopharmacol; 2020 Nov; 23(8):496-504. PubMed ID: 32710539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypersexuality and other impulse control disorders in Parkinson's disease].
    Nelis EA; Berendse HW; van den Heuvel OA
    Ned Tijdschr Geneeskd; 2016; 160():A9359. PubMed ID: 26732226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced impulse control disorders: a review.
    Atmaca M
    Curr Clin Pharmacol; 2014 Feb; 9(1):70-4. PubMed ID: 24219002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced compulsive behaviors: exceptions to the rule.
    Graham NA; Hammond CJ; Gold MS
    Mayo Clin Proc; 2009 Sep; 84(9):846-7; author reply 847. PubMed ID: 19720785
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypersexuality Possibly Associated With Safinamide.
    Jiménez-Jiménez FJ; Alonso-Navarro H; Valle-Arcos D
    J Clin Psychopharmacol; 2017 Oct; 37(5):635-636. PubMed ID: 28796020
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine Agonist Withdrawal Syndrome and Suicidality in Parkinson's Disease.
    Kwan C; Kolivakis T; Huot P
    Can J Neurol Sci; 2023 Sep; 50(5):779-780. PubMed ID: 35801613
    [No Abstract]   [Full Text] [Related]  

  • 19. A Multicenter Comparative Study of Impulse Control Disorder in Latin American Patients With Parkinson Disease.
    Ramírez Gómez CC; Serrano Dueñas M; Bernal O; Araoz N; Sáenz Farret M; Aldinio V; Montilla V; Micheli F
    Clin Neuropharmacol; 2017; 40(2):51-55. PubMed ID: 28288482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.